Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis
Objective To estimate the association between the use of sodium glucose co-transporter-2
(SGLT2) inhibitors and postmarket harms as identified by drug regulatory agencies. Design …
(SGLT2) inhibitors and postmarket harms as identified by drug regulatory agencies. Design …
Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis
JR Donnan, CA Grandy, E Chibrikov, CA Marra… - BMJ …, 2019 - search.proquest.com
Objective To estimate the association between the use of sodium glucose co-transporter-2
(SGLT2) inhibitors and postmarket harms as identified by drug regulatory agencies. Design …
(SGLT2) inhibitors and postmarket harms as identified by drug regulatory agencies. Design …
[PDF][PDF] Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis
JR Donnan, CA Grandy, E Chibrikov, CA Marra… - academia.edu
Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic
review and meta-analysis Page 1 1 Donnan JR, et al. BMJ Open 2019;9:e022577. doi:10.1136/bmjopen-2018-022577 …
review and meta-analysis Page 1 1 Donnan JR, et al. BMJ Open 2019;9:e022577. doi:10.1136/bmjopen-2018-022577 …
Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis.
JR Donnan, CA Grandy, E Chibrikov, CA Marra… - BMJ Open, 2019 - europepmc.org
Objective To estimate the association between the use of sodium glucose co-transporter-2
(SGLT2) inhibitors and postmarket harms as identified by drug regulatory agencies. Design …
(SGLT2) inhibitors and postmarket harms as identified by drug regulatory agencies. Design …
Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis
JR Donnan, CA Grandy, E Chibrikov, CA Marra… - BMJ Open, 2019 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Objective</jats: title>< jats: p> To estimate the association
between the use of sodium glucose co-transporter-2 (SGLT2) inhibitors and postmarket …
between the use of sodium glucose co-transporter-2 (SGLT2) inhibitors and postmarket …
Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis
JR Donnan, CA Grandy, E Chibrikov, CA Marra… - BMJ …, 2019 - pubmed.ncbi.nlm.nih.gov
Objective To estimate the association between the use of sodium glucose co-transporter-2
(SGLT2) inhibitors and postmarket harms as identified by drug regulatory agencies. Design …
(SGLT2) inhibitors and postmarket harms as identified by drug regulatory agencies. Design …
[HTML][HTML] Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis
JR Donnan, CA Grandy, E Chibrikov, CA Marra… - BMJ Open, 2019 - ncbi.nlm.nih.gov
Objective To estimate the association between the use of sodium glucose co-transporter-2
(SGLT2) inhibitors and postmarket harms as identified by drug regulatory agencies. Design …
(SGLT2) inhibitors and postmarket harms as identified by drug regulatory agencies. Design …
[PDF][PDF] Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis
JR Donnan, CA Grandy, E Chibrikov, CA Marra… - academia.edu
Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic
review and meta-analysis Page 1 1 Donnan JR, et al. BMJ Open 2019;9:e022577. doi:10.1136/bmjopen-2018-022577 …
review and meta-analysis Page 1 1 Donnan JR, et al. BMJ Open 2019;9:e022577. doi:10.1136/bmjopen-2018-022577 …